Moderately to Severely Active Ulcerative Colitis (UC)
1 clinical trials · Condition
◉ Watch Moderately to Severely Active Ulcerative Colitis (UC)
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2) (NCT07535489) | Nanjing Immunophage Biotech Co., Ltd | 2026-07-07 |
Track Moderately to Severely Active Ulcerative Colitis (UC) automatically
Every clearance here is in the API, with alerts when new ones post.